25 related articles for article (PubMed ID: 7691191)
1. Potential role of oxidative stress in pathogenesis of benign prostatic hyperplasia in male dogs.
Domosławska-Wyderska A; Zduńczyk S; Rafalska A
Reprod Domest Anim; 2024 May; 59(5):e14580. PubMed ID: 38698701
[TBL] [Abstract][Full Text] [Related]
2. Contrast-Enhanced Ultrasound (CEUS) Evaluation of Canine Prostatic Hyperplasia before and after Osaterone Acetate Therapy: Preliminary Results.
Pettina G; Bucci R; Mazzetti A; Quartuccio M; Robbe D; Pisu MC
Animals (Basel); 2024 Jun; 14(11):. PubMed ID: 38891730
[TBL] [Abstract][Full Text] [Related]
3. Comparative Evaluation of Diagnostic Methods for Subclinical Benign Prostatic Hyperplasia in Intact Breeding Male Dogs.
Laurusevičius T; Šiugždaitė J; Juodžiukynienė N; Kerzienė S; Anskienė L; Jackutė V; Trumbeckas D; Van Soom A; Posastiuc FP; Žilinskas H
Animals (Basel); 2024 Apr; 14(8):. PubMed ID: 38672352
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
5. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
[TBL] [Abstract][Full Text] [Related]
6. Short-term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate.
Orima H; Shimizu M; Tsutsui T; Kawakami E; Ogasa A
J Vet Med Sci; 1995 Feb; 57(1):139-41. PubMed ID: 7538794
[TBL] [Abstract][Full Text] [Related]
7. Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
Shimizu M; Tsutsui T; Kawakami E; Hori T; Fujita M; Orima H; Ogasa A
J Vet Med Sci; 1995 Jun; 57(3):395-9. PubMed ID: 7548388
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
Ito K; Fukabori Y; Shibata Y; Suzuki K; Mieda M; Gotanda K; Honma S; Yamanaka H
Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Makanae Y; Yajima K; Ogasa A
J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
[TBL] [Abstract][Full Text] [Related]
10. [Transurethral resection for prostatic adenoma larger than 100 ml--preoperative treatment with interstitial laser coagulation of the prostate plus chlormadinone acetate as a treatment maneuver for safer operations].
Furuya S; Furuya R; Ogura H; Shimamura S; Araki T
Hinyokika Kiyo; 2005 Mar; 51(3):159-64. PubMed ID: 15852668
[TBL] [Abstract][Full Text] [Related]
11. Profile of the progesterone derivative chlormadinone acetate - pharmocodynamic properties and therapeutic applications.
Druckmann R
Contraception; 2009 Apr; 79(4):272-81. PubMed ID: 19272496
[TBL] [Abstract][Full Text] [Related]
12. Prostatic disorders in the dog.
Johnston SD; Kamolpatana K; Root-Kustritz MV; Johnston GR
Anim Reprod Sci; 2000 Jul; 60-61():405-15. PubMed ID: 10844211
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
